US Procedure Numbers for Cardiac Surgery and Heart Valve Devices 2018 - MedPro

  • ID: 4435251
  • Report
  • Region: United States
  • 408 pages
  • iData Research
15 % OFF
until Oct 31st 2018
1 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Boston Scientific
  • Cryolife
  • Karl Storz
  • Microline Surgical
  • SentreHeart
  • MORE
Recently, minimally invasive cardiac surgery has started to gain popularity among surgeons and patients. Minimally invasive procedures allow for reduced hospitalization and less scarring. The growth of the minimally invasive procedures comes from the cannibalization of the open-heart surgery procedures. Currently, many types of minimally invasive procedures do not have FDA approval. As more products get FDA approved, the minimally invasive procedures are expected to grow at a much higher rate and cause the open-heart procedures to decline.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Boston Scientific
  • Cryolife
  • Karl Storz
  • Microline Surgical
  • SentreHeart
  • MORE
EXECUTIVE SUMMARY
U.S. CARDIAC SURGERY AND HEART VALVE DEVICE MARKET OVERVIEW
COMPETITIVE ANALYSIS
MARKET TRENDS
MARKET DEVELOPMENTS
PROCEDURE NUMBERS
PROCEDURE CODES INVESTIGATED
MARKETS INCLUDED
KEY REPORT UPDATES
VERSION HISTORY

1. RESEARCH METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecasts and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring

2. DISEASE OVERVIEW
2.1 BASIC ANATOMY
2.1.11 Coronary Artery Disease
2.1.12 Myocardial Infarction
2.1.13 Angina Pectoris
2.1.14 Heart Valve Disease
2.1.15 Congestive Heart Failure
PROCEDURE NUMBERS
3.1 INTRODUCTION
3.2 CARDIAC SURGERY AND HEART VALVE PROCEDURES
3.3 SURGICAL HEART VALVE REPLACEMENT PROCEDURES
3.3.1 Tissue Heart Valve Procedures by Valve Type
3.3.2 Tissue Heart Valve Procedures by Device Type
3.3.3 Tissue Heart Valve Procedures by Tissue Type
3.3.4 Mechanical Heart Valve Procedures by Valve Type
3.3.5 Mechanical Heart Valve Procedures by Tissue Type
3.4 ANNULOPLASTY REPAIR PROCEDURES
3.4.1 Annuloplasty Repair Procedures by Valve Type
3.4.2 Annuloplasty Repair Procedures by Device Type
3.5 TRANSCATHETER MITRAL HEART VALVE REPAIR PROCEDURES
3.6 TRANSCATHETER AORTIC HEART VALVE REPLACEMENT PROCEDURES
3.6.1 Transcatheter Aortic Heart Valve Replacement Procedures by Approach
3.6.2 Transcatheter Aortic Heart Valve Replacement Procedures by Patient Risk Class
3.7 CABG PROCEDURES
3.7.1 CABG Procedures by Support Type
3.7.2 CABG Vessel Harvesting Procedures by Type
3.7.3 CABG Procedures by Suture Type
3.8 TRANSMYOCARDIAL REVASCULARIZATION PROCEDURES
3.9 VENTRICULAR ASSIST DEVICE PROCEDURES
3.9.1 Ventricular Assist Procedures by Device Type
3.9.1.1 Percutaneous Ventricular Assist Procedures by Indication
3.9.1.2 Implantable Ventricular Assist Procedures by Indication
3.9.1.3 Implantable Ventricular Assist Procedures by Area
3.9.1.4 External Ventricular Assist Procedures by Device Type
3.10 INTRA-AORTIC BALLOON PUMP PROCEDURES
3.10.1 Intra-Aortic Balloon Pump Procedures by Setting
3.10.2 Intra-Aortic Balloon Pump Procedures by Device Type
3.11 TEMPORARY ARTIFICIAL HEART PROCEDURES
3.12 REMOTE HEMODYNAMIC MONITORING PROCEDURES
3.13 PATENT FORAMEN OVALE CLOSURE PROCEDURES
3.14 SEPTAL DEFECT CLOSURE PROCEDURES
3.14.1 Septal Defect Closure Procedures by Type
3.15 LEFT ATRIAL APPENDAGE CLOSURE PROCEDURES
3.15.1 Left Atrial Appendage Closure Procedures by Type
3.15.1.1 Epicardial Device Procedures by Type
3.15.1.1.1 Epicardial Clip Device Procedures by Type

ABBREVIATIONS

APPENDIX: COMPANY PRESS RELEASES

List of Charts
Chart 1 1: Cardiac Surgery and Heart Valve Devices Market by Segment, U.S., 2014 – 2024
Chart 1 2: Cardiac Surgery and Heart Valve Devices Market Overview, U.S., 2017 & 2024
Chart 5 1: Cardiac Surgery and Heart Valve Device Procedures, U.S., 2014 – 2024
Chart 5 2: Surgical Heart Valve Replacement Procedures by Device Type, U.S., 2014 – 2024
Chart 5 3: Tissue Heart Valve Procedures by Valve Type, U.S., 2014 – 2024
Chart 5 4: Tissue Heart Valve Procedures by Device Type, U.S., 2014 – 2024
Chart 5 5: Tissue Heart Valve Procedures by Tissue Type, U.S., 2014 – 2024
Chart 5 6: Mechanical Heart Valve Procedures by Valve Type, U.S., 2014 – 2024
Chart 5 7: Mechanical Heart Valve Procedures by Tissue Type, U.S., 2014 – 2024
Chart 5 8: Annuloplasty Repair Procedures by Valve Type, U.S., 2014 – 2024
Chart 5 9: Annuloplasty Repair Procedures by Device Type, U.S., 2014 – 2024
Chart 5 10: Transcatheter Heart Valve Repair Procedures, U.S., 2014 – 2024
Chart 5 11: Transcatheter Aortic Heart Valve Replacement Procedures by Valve Type, U.S., 2014 – 2024
Chart 5 12: Transcatheter Aortic Heart Valve Replacement Procedures by Approach, U.S., 2014 – 2024
Chart 5 13: Transcatheter Aortic Heart Valve Replacement Procedures by Patient Risk Class, U.S., 2017
Chart 5 14: CABG Procedures by Support Type, U.S., 2014 – 2024
Chart 5 15: CABG Vessel Harvesting Procedures by Type, U.S., 2014 – 2024
Chart 5 16: CABG Procedures by Suture Type, U.S., 2014 – 2024
Chart 5 17: Transmyocardial Revascularization Procedures, U.S., 2014 – 2024
Chart 5 18: Ventricular Assist Procedures by Device Type, U.S., 2014 – 2024
Chart 5 19: Percutaneous Ventricular Assist Procedures by Indication, U.S., 2014 – 2024
Chart 5 20: Implantable Ventricular Assist Procedures by Indication, U.S., 2014 – 2024
Chart 5 21: Implantable Ventricular Assist Procedures by Indication, U.S., 2014 – 2024
Chart 5 22: External Ventricular Assist Procedures by Device Type, U.S., 2014 – 2024
Chart 5 23: Intra-Aortic Balloon Pump Procedures by Setting, U.S., 2014 – 2024
Chart 5 24: Intra-Aortic Balloon Pump Procedures by Device Type, U.S., 2014 – 2024
Chart 5 25: Heart Replacement Procedures by Type, U.S., 2014 – 2024
Chart 5 26: Remote Hemodynamic Monitoring Device Implantation Procedures, U.S., 2014 – 2024
Chart 5 27: Patent Foramen Ovale Closure Procedures, U.S., 2014 – 2024
Chart 5 28: Septal Defect Closure Procedures by Type, U.S., 2014 – 2024
Chart 5 29: Left Atrial Appendage Closure Procedures by Type, U.S., 2014 – 2024
Chart 5 30: Epicardial Device Procedures by Type, U.S., 2014 – 2024
Chart 5 31: Epicardial Clip Device Procedures by Type, U.S., 2014 – 2024

List of Figures:
Figure 1 1: Cardiac Surgery and Heart Valve Devices Market Share Ranking by Segment, U.S., 2017 (1 of 4)
Figure 1 2: Cardiac Surgery and Heart Valve Devices Market Share Ranking by Segment, U.S., 2017 (2 of 4)
Figure 1 3: Cardiac Surgery and Heart Valve Devices Market Share Ranking by Segment, U.S., 2017 (3 of 4)
Figure 1 4: Cardiac Surgery and Heart Valve Devices Market Share Ranking by Segment, U.S., 2017 (4 of 4)
Figure 1 5: Companies Researched in this Report, U.S., 2017
Figure 1 6: Factors Impacting the Cardiac Surgery and Heart Valve Devices Market by Segment, U.S. (1 of 4)
Figure 1 7: Factors Impacting the Cardiac Surgery and Heart Valve Devices Market by Segment, U.S. (2 of 4)
Figure 1 8: Factors Impacting the Cardiac Surgery and Heart Valve Devices Market by Segment, U.S. (3 of 4)
Figure 1 9: Factors Impacting the Cardiac Surgery and Heart Valve Devices Market by Segment, U.S. (4 of 4)
Figure 1 10: Recent Events in the Cardiac Surgery and Heart Valve Devices Market, U.S., 2015 – 2017
Figure 1 11: Cardiac Surgery and Heart Valve Devices Procedures Covered, U.S., 2017 (1 of 4)
Figure 1 12: Cardiac Surgery and Heart Valve Devices Procedures Covered, U.S., 2017 (2 of 4)
Figure 1 13: Cardiac Surgery and Heart Valve Devices Procedures Covered, U.S., 2017 (3 of 4)
Figure 1 14: Cardiac Surgery and Heart Valve Devices Procedures Covered, U.S., 2017 (4 of 4)
Figure 1 15: Procedure Codes Investigated, U.S., 2017
Figure 1 16: Cardiac Surgery and Heart Valve Devices Markets Covered, U.S., 2017 (1 of 2)
Figure 1 17: Cardiac Surgery and Heart Valve Devices Markets Covered, U.S., 2017 (2 of 2)
Figure 1 18: Key Report Updates (1 of 2)
Figure 1 19: Key Report Updates (2 of 2)
Figure 1 20: Version History
Figure 5 1: Cardiac Surgery and Heart Valve Device Procedures, U.S., 2014 – 2024 (1 of 3)
Figure 5 2: Cardiac Surgery and Heart Valve Device Procedures, U.S., 2014 – 2024 (2 of 3)
Figure 5 3: Cardiac Surgery and Heart Valve Device Procedures, U.S., 2014 – 2024 (3 of 3)
Figure 5 4: Surgical Heart Valve Replacement Procedures by Device Type, U.S., 2014 – 2024
Figure 5 5: Tissue Heart Valve Procedures by Valve Type, U.S., 2014 – 2024
Figure 5 6: Tissue Heart Valve Procedures by Device Type, U.S., 2014 – 2024
Figure 5 7: Tissue Heart Valve Procedures by Tissue Type, U.S., 2014 – 2024
Figure 5 8: Mechanical Heart Valve Procedures by Valve Type, U.S., 2014 – 2024
Figure 5 9: Mechanical Heart Valve Procedures by Tissue Type, U.S., 2014 – 2024
Figure 5 10: Annuloplasty Repair Procedures by Valve Type, U.S., 2014 – 2024
Figure 5 11: Annuloplasty Repair Procedures by Device Type, U.S., 2014 – 2024
Figure 5 12: Transcatheter Mitral Heart Valve Repair Procedures, U.S., 2014 – 2024
Figure 5 13: Transcatheter Aortic Heart Valve Replacement Procedures by Valve Type, U.S., 2014 – 2024
Figure 5 14: Transcatheter Aortic Heart Valve Replacement Procedures by Approach, U.S., 2014 – 2024
Figure 5 15: Transcatheter Aortic Heart Valve Replacement Procedures by Patient Risk Class, U.S., 2017
Figure 5 16: CABG Procedures by Support Type, U.S., 2014 – 2024
Figure 5 17: CABG Procedure Penetration Rates, U.S., 2014 – 2024
Figure 5 18: CABG Vessel Harvesting Procedures by Type, U.S., 2014 – 2024
Figure 5 19: CABG Procedures by Suture Type, U.S., 2014 – 2024
Figure 5 20: Transmyocardial Revascularization Procedures, U.S., 2014 – 2024
Figure 5 21: Ventricular Assist Procedures by Device Type, U.S., 2014 – 2024
Figure 5 22: Percutaneous Ventricular Assist Procedures by Indication, U.S., 2017
Figure 5 23: Implantable Ventricular Assist Procedures by Indication, U.S., 2014 – 2024
Figure 5 24: Implantable Ventricular Assist Procedures by Indication, U.S., 2014 – 2024
Figure 5 25: External Ventricular Assist Procedures by Device Type, U.S., 2014 – 2024
Figure 5 26: Intra-Aortic Balloon Pump Procedures by Setting, U.S., 2014 – 2024
Figure 5 27: Intra-Aortic Balloon Pump Procedures by Device Type, U.S., 2014 – 2024
Figure 5 28: Heart Replacement Procedures by Type, U.S., 2014 – 2024
Figure 5 29: Remote Hemodynamic Monitoring Device Implantation Procedures, U.S., 2014 – 2024
Figure 5 30: Patent Foramen Ovale Closure Procedures, U.S., 2014 – 2024
Figure 5 31: Septal Defect Closure Procedures by Type, U.S., 2014 – 2024
Figure 5 32: Left Atrial Appendage Closure Procedures by Type, U.S., 2014 – 2024
Figure 5 33: Epicardial Device Procedures by Type, U.S., 2014 – 2024
Figure 5 34: Epicardial Clip Device Procedures by Type, U.S., 2014 – 2024
Figure 25 1: Press Release Summary
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Edwards Lifesciences
  • St. Jude Medical
  • Medtronic
  • Maquet
  • Abiomed
  • HeartWare Inc.
  • Sorin Group
  • Terumo
  • Abbott Laboratories
  • Teleflex Medical
  • Cardiac Assist
  • AtriCure
  • W.L. Gore
  • SynCardia
  • Boston Scientific
  • Cryolife
  • Berlin Heart
  • Cardica
  • Chase Medical
  • Genesee Biomedical
  • Karl Storz
  • LifeNet Health
  • Microline Surgical
  • Novadaq
  • On-X
  • Saphena Medical
  • SentreHeart
  • Vitalitec
Please Note: Not all companies are currently active in every segment or sub-report from this suite.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll